Risk for Suicidal Ideation, Attempts Down With GLP1-RA Treatment in Teens With Obesity
By Elana Gotkine HealthDay Reporter
TUESDAY, Oct. 15, 2024 -- For adolescents with obesity, glucagon-like peptide 1 receptor agonist (GLP1-RA) treatment is associated with a reduced risk for suicidal ideation or attempts, according to a study published online Oct. 14 in JAMA Pediatrics.
Liya Kerem, M.D., and Joshua Stokar, M.D., from Hadassah University Medical Center in Israel, examined the incidence of suicidal ideation or attempts following initial prescription of GLP1-RA (study cohort) or a lifestyle intervention without GLP1-RA treatment (control cohort) in a retrospective propensity score-matched cohort. Participants were adolescents aged 12 to 18 years with a diagnosis of obesity and evidence of an antiobesity GLP1-RA prescription or lifestyle intervention without GLP1-RA treatment; after propensity score matching, 3,456 participants were included in each cohort.
The researchers found that the study cohort had a significantly lower risk for suicidal ideation or attempts during 12 months of follow-up (1.45 versus 2.26 percent; hazard ratio, 0.67) and a significantly higher rate of gastrointestinal symptoms, used as a positive control outcome (6.9 versus 5.4 percent; hazard ratio, 1.41). There was no difference between the groups in the rates of upper respiratory tract infection diagnoses, used as a negative control outcome.
"Future prospective studies should assess the association of GLP1-RA treatment with psychiatric outcomes in adolescents with obesity," the authors write.
One author disclosed ties to Novo Nordisk.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted October 2024
Read this next
One in 10 Mental Health-Related ED Visits Among Youths Involve Boarding
WEDNESDAY, Aug. 20, 2025 -- Boarding is a considerable issue for Medicaid-enrolled youths seeking mental health care in emergency departments (EDs), according to a research letter...
College Students With Autism Report Higher Rates of Anxiety, Depression
TUESDAY, Aug. 19, 2025 -- College students with autism face higher rates of anxiety and depression than students without autism, according to a study recently published online in...
PFAS Exposure Linked to Teen Weight Regain After Bariatric Surgery
TUESDAY, Aug. 19, 2025 -- For adolescents, exposure to perfluoroalkyl and polyfluoroalkyl substances (PFAS) is associated with weight regain after bariatric surgery, according to...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.